Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.
Gorelick RJ, Benveniste RE, Lifson JD, Yovandich JL, Morton WR, Kuller L, Flynn BM, Fisher BA, Rossio JL, Piatak M Jr, Bess JW Jr, Henderson LE, Arthur LO. Gorelick RJ, et al. Among authors: arthur lo. J Virol. 2000 Dec;74(24):11935-49. doi: 10.1128/jvi.74.24.11935-11949.2000. J Virol. 2000. PMID: 11090194 Free PMC article.
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
Chertova E, Bess JW Jr, Crise BJ, Sowder II RC, Schaden TM, Hilburn JM, Hoxie JA, Benveniste RE, Lifson JD, Henderson LE, Arthur LO. Chertova E, et al. Among authors: arthur lo. J Virol. 2002 Jun;76(11):5315-25. doi: 10.1128/jvi.76.11.5315-5325.2002. J Virol. 2002. PMID: 11991960 Free PMC article.
Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles.
Willey RL, Byrum R, Piatak M, Kim YB, Cho MW, Rossio JL Jr, Bess J Jr, Igarashi T, Endo Y, Arthur LO, Lifson JD, Martin MA. Willey RL, et al. Among authors: arthur lo. J Virol. 2003 Jan;77(2):1163-74. doi: 10.1128/jvi.77.2.1163-1174.2003. J Virol. 2003. PMID: 12502833 Free PMC article.
Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.
Lifson JD, Rossio JL, Piatak M Jr, Bess J Jr, Chertova E, Schneider DK, Coalter VJ, Poore B, Kiser RF, Imming RJ, Scarzello AJ, Henderson LE, Alvord WG, Hirsch VM, Benveniste RE, Arthur LO. Lifson JD, et al. Among authors: arthur lo. AIDS Res Hum Retroviruses. 2004 Jul;20(7):772-87. doi: 10.1089/0889222041524661. AIDS Res Hum Retroviruses. 2004. PMID: 15307924
Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.
Gorelick RJ, Chabot DJ, Ott DE, Gagliardi TD, Rein A, Henderson LE, Arthur LO. Gorelick RJ, et al. Among authors: arthur lo. J Virol. 1996 Apr;70(4):2593-7. doi: 10.1128/JVI.70.4.2593-2597.1996. J Virol. 1996. PMID: 8642691 Free PMC article.
151 results